Press Releases
Red Queen Therapeutics Announces Expanded Licensing Agreement, Progress in Its Pan-Influenza Program
December 3, 2024
Expanded agreement with Dana-Farber Cancer Institute enables further acceleration of Red Queen program in SARS-CoV-2 and advanced delivery options Red...
